CDTX logo

Cidara Therapeutics (CDTX) Total Liabilities

Annual Total Liabilities

$75.24 M
+$13.31 M+21.50%

31 December 2023

CDTX Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$46.70 M
+$4.28 M+10.09%

30 September 2024

CDTX Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CDTX Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+21.5%-15.8%
3 y3 years+51.4%-10.8%
5 y5 years+276.7%+42.7%

CDTX Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+51.4%-37.9%+10.1%
5 y5 yearsat high+276.7%-37.9%+53.9%
alltimeall timeat high+4605.4%-40.4%+1408.4%

Cidara Therapeutics Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$46.70 M(+10.1%)
June 2024
-
$42.42 M(-39.8%)
Mar 2024
-
$70.50 M(-6.3%)
Dec 2023
$75.24 M(+21.5%)
$75.24 M(+35.7%)
Sept 2023
-
$55.43 M(+5.4%)
June 2023
-
$52.57 M(-4.2%)
Mar 2023
-
$54.90 M(-11.3%)
Dec 2022
$61.92 M(+15.2%)
$61.92 M(+7.2%)
Sept 2022
-
$57.79 M(+21.7%)
June 2022
-
$47.48 M(-5.7%)
Mar 2022
-
$50.34 M(-6.4%)
Dec 2021
$53.75 M(+8.1%)
$53.75 M(+2.7%)
Sept 2021
-
$52.36 M(+9.2%)
June 2021
-
$47.95 M(-8.3%)
Mar 2021
-
$52.32 M(+5.2%)
Dec 2020
$49.71 M(+59.6%)
$49.71 M(+45.7%)
Sept 2020
-
$34.12 M(+6.4%)
June 2020
-
$32.05 M(+5.6%)
Mar 2020
-
$30.34 M(-2.6%)
Dec 2019
$31.14 M
$31.14 M(-4.9%)
DateAnnualQuarterly
Sept 2019
-
$32.73 M(+63.9%)
June 2019
-
$19.97 M(-2.4%)
Mar 2019
-
$20.45 M(+2.4%)
Dec 2018
$19.97 M(+3.5%)
$19.97 M(-12.7%)
Sept 2018
-
$22.88 M(-8.0%)
June 2018
-
$24.87 M(+28.7%)
Mar 2018
-
$19.33 M(+0.2%)
Dec 2017
$19.29 M(+2.7%)
$19.29 M(+14.4%)
Sept 2017
-
$16.86 M(-15.2%)
June 2017
-
$19.89 M(+18.6%)
Mar 2017
-
$16.77 M(-10.7%)
Dec 2016
$18.78 M(+209.8%)
$18.78 M(+125.8%)
Sept 2016
-
$8.32 M(+59.5%)
June 2016
-
$5.21 M(+25.8%)
Mar 2016
-
$4.14 M(-31.6%)
Dec 2015
$6.06 M(-83.1%)
$6.06 M(+38.9%)
Sept 2015
-
$4.36 M(+40.9%)
June 2015
-
$3.10 M(-96.0%)
Mar 2015
-
$78.31 M(+118.8%)
Dec 2014
$35.80 M(+2138.6%)
$35.80 M
Dec 2013
$1.60 M
-

FAQ

  • What is Cidara Therapeutics annual total liabilities?
  • What is the all time high annual total liabilities for Cidara Therapeutics?
  • What is Cidara Therapeutics annual total liabilities year-on-year change?
  • What is Cidara Therapeutics quarterly total liabilities?
  • What is the all time high quarterly total liabilities for Cidara Therapeutics?
  • What is Cidara Therapeutics quarterly total liabilities year-on-year change?

What is Cidara Therapeutics annual total liabilities?

The current annual total liabilities of CDTX is $75.24 M

What is the all time high annual total liabilities for Cidara Therapeutics?

Cidara Therapeutics all-time high annual total liabilities is $75.24 M

What is Cidara Therapeutics annual total liabilities year-on-year change?

Over the past year, CDTX annual total liabilities has changed by +$13.31 M (+21.50%)

What is Cidara Therapeutics quarterly total liabilities?

The current quarterly total liabilities of CDTX is $46.70 M

What is the all time high quarterly total liabilities for Cidara Therapeutics?

Cidara Therapeutics all-time high quarterly total liabilities is $78.31 M

What is Cidara Therapeutics quarterly total liabilities year-on-year change?

Over the past year, CDTX quarterly total liabilities has changed by -$8.73 M (-15.75%)